Discover why Novo Nordisk's current sell-off offers a strong buy opportunity. Backed by solid fundamentals, growth prospects, ...

DexCom has significant room to grow in its core market, despite disappointing results last year. One of Warren Buffett's ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Faced with geopolitical upheaval, economic volatility and technological disruption, directors are swiftly dismissing bosses ...

The country’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, the UK’s official system for ...

Market quiet, Nifty futures subdued, Asian markets lower. Analysts predict benefits for Indian contract manufacturers from ...

Wall Street hits record highs as payrolls surge. Explore healthcare stock movers, obesity drug breakthroughs, AbbVie deals, Centene struggles & ...

Overweight and obesity are growing public health challenges in the Philippines. In just over two decades, the prevalence of overweight and obesity among Filipino adults has doubled, rising from 20% in ...